Yale Program for Recovery and Community Health, Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
Analytics and Innovation, Beacon Health Options, Boston, MA, USA.
Psychiatr Q. 2020 Jun;91(2):533-545. doi: 10.1007/s11126-019-09681-w.
The purpose of the study is to 1) better understand patterns of utilization of Intensive Outpatient Treatment (IOP) Programs and Services in the State of Connecticut by adult Medicaid recipients experiencing a serious mental illness, substance use disorder, or co-occurring disorders; and 2) to determine the relationship between the duration of an IOP episode and connection to care rates for higher (i.e., rehospitalization) or lower levels of care following discharge. We hypothesized that the duration of an IOP episode would impact positively in reducing the use of higher levels of care while increasing the use of lower levels of care. In order to examine the frequency and duration of use of Intensive Outpatient (IOP) services by the CT Medicaid population, a two-year timeframe was selected: July 1, 2012 to June 30, 2014. A survival analysis was conducted to assess the risk of readmission to an IOP within 180 days based on demographic and utilization factors including, Age (in years on date of discharge), Race and Ethnicity, Gender, Homeless Status (at least one day in CY 2013), and Engagement Group (Intent to Treat, Early Termination, Minimally Adequate Dosage, & Target or More). To better understand the patterns of utilization associated with Adult IOP services, the average length of stay, number of treatment days, and average number of treatment days per week were explored. The number of unique individuals who were part of this analysis is 11,473, of which 2050 were mental health IOP utilizers (18%), 4598 were co-occurring IOP utilizers (40%), and 4825 (42%) were substance use IOP utilizers. For the total population, the average length of stay (ALOS) in days was 42 and the average number of treatment days attended per week was 2.5, for an average of 15 treatment days per episode of care. Among the IOP Cohorts, the Mental Health Cohort had the longest ALOS at 44.15 days, an average of 2.34 days of service per week, for an average of 14.76 days of IOP service per episode of care. The Substance Use Cohort had the shortest ALOS at 41.33 days, but had the highest intensity of services per week at 2.71 for an average of 16 days of service per episode of care. The Co-Occurring Cohort presented an ALOS of 41.74 days, an average of 2.32 services per week and an average of 13.83 sessions per episode. Overall there is evidence supporting an association between the number of days of care and protection from hospitalization, up to a certain number of days of care or number of days in IOP. Above the Minimally Adequate Dosage, the IOP protection factor seems to reach a plateau. This means that after 16 days of care, the chances of hospitalization remain the same regardless of the additional days provided.
1)更好地了解康涅狄格州成年医疗补助受助人在经历严重精神疾病、药物使用障碍或共病时使用强化门诊治疗(IOP)计划和服务的模式;2)确定 IOP 发作持续时间与出院后更高(即再住院)或更低水平护理的连接率之间的关系。我们假设 IOP 发作的持续时间将对降低更高水平护理的使用和增加较低水平护理的使用产生积极影响。为了检查 CT 医疗补助人群对强化门诊(IOP)服务的使用频率和持续时间,选择了两年的时间范围:2012 年 7 月 1 日至 2014 年 6 月 30 日。进行生存分析以根据人口统计学和利用因素评估在 180 天内重新入院 IOP 的风险,包括年龄(出院日期的年龄)、种族和民族、性别、无家可归状况(2013 年至少一天)和参与组(意向治疗、提前终止、最小足够剂量和目标或更多)。为了更好地了解与成人 IOP 服务相关的使用模式,探讨了平均住院时间、治疗天数和每周平均治疗天数。参与此项分析的独特个体人数为 11473 人,其中 2050 人为心理健康 IOP 用户(18%),4598 人为共病 IOP 用户(40%),4825 人为药物使用 IOP 用户(42%)。对于总人口,住院时间(ALOS)的平均值为 42 天,每周参加治疗的平均天数为 2.5 天,每次护理的平均治疗天数为 15 天。在 IOP 队列中,心理健康队列的 ALOS 最长,为 44.15 天,每周平均服务 2.34 天,每次护理的平均 IOP 服务为 14.76 天。物质使用队列的 ALOS 最短,为 41.33 天,但每周服务强度最高,为 2.71,每次护理的平均服务时间为 16 天。共同发病队列的 ALOS 为 41.74 天,每周平均服务 2.32 次,每次发病平均 13.83 次。总体而言,有证据表明护理天数与住院保护之间存在关联,直到达到一定天数的护理或 IOP 天数。在最小足够剂量以上,IOP 保护因子似乎达到了一个平台。这意味着在接受 16 天的护理后,无论提供多少额外的护理,住院的机会仍然相同。